Diaz J, Sternber CN, Mehmud F, Delea TE, Latimer N, Pandite L, Motzer RJ. Overall survival endpoint in oncology clinical trials: Addressing the effect of crossover – The case of pazopanib in advanced renal cell carcinoma. Oncology 2016;90(3):119-26. - PAI - Policy Analysis Inc.

Diaz J, Sternber CN, Mehmud F, Delea TE, Latimer N, Pandite L, Motzer RJ. Overall survival endpoint in oncology clinical trials: Addressing the effect of crossover – The case of pazopanib in advanced renal cell carcinoma. Oncology 2016;90(3):119-26. - PAI - Policy Analysis Inc.